Macrophage proteome modulation induced by tribocorrosion of graphene oxide–hyaluronic acid-coated CoCr surfaces
Biomedical Materials · 01.08.2026 · 21 (4) · 045033
DOI: 10.1088/1748-605x/ae92e2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Materials, online erschienen am 12.08.2026. Verfasst von L Sánchez-López und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigaciones Biológicas-Margarita Salas (CIB Margarita Salas), Consejo Superior de Investigaciones Científicas (CSIC), C/ Ramiro de Maez…. Hauptthemen laut MEDLINE: Graphite, Hyaluronic Acid, Macrophages, Coated Materials, Biocompatible. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MICIU, Ministerio de Ciencia, Innovación y Universidades (MICIU/FEDER) in Spain.
Abstract (Originalsprache)
Hip and knee implant components, such as femoral bearings, acetabulum liners, and stem taper junctions are subjected to mechanical stresses and undergo electrochemical processes that compromise their functionality. Cobalt-chromium (CoCr) alloys are widely used as implants owing to their excellent mechanical properties, corrosion resistance, and biocompatibility. However, they are susceptible to simultaneous surface processes of wear and corrosion, known as tribocorrosion, which reduce their longevity and impact their performance. Our group has developed covalent multifunctional nanocoatings of graphene oxide (GO) and hyaluronic acid (HA) on CoCr surfaces providing chemical protection, reducing inflammatory response and enhancing wear-corrosion resistance. However, when the GO/HA nanocoating is disrupted by tribocorrosion, as takes place under in vivo conditions, macrophages, crucial cells for inflammation and healing, could exhibit a significantly different proteome. For this purpose, CoCr modified GO/HA surfaces were configured in a tribometer to simulate tribocorrosion of CoCrMo/CoCrMo joint implants, and the biological effects were studied in murine macrophages and analyzed via high-throughput proteomics. Simulated tribocorrosion testing revealed that metal degradation activates phagocytosis and increases endo-lysosomal membrane proteins, indicating enriched phagosomal compartment formation in macrophages. Additionally, macrophage exposure to worn CoCr-modified surfaces activates metal sensitization mechanisms and antigen presentation, leading to macrophage activation and polarization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Investigaciones Biológicas-Margarita Salas (CIB Margarita Salas), Consejo Superior de Investigaciones Científicas (CSIC), C/ Ramiro de Maeztu, 28040 Madrid, Spain.
- Centro Nacional de Investigaciones Metalúrgicas (CENIM), Consejo Superior de Investigaciones Científicas (CSIC), Avenida Gregorio del Amo, 8, 28040 Madrid, Spain.
- PhD Program in Advanced Materials and Nanotechnology, Doctoral School, Universidad Autónoma de Madrid, Ciudad Universitaria de Cantoblanco, 28049 Madrid, Spain.
ORCID-Profile: L Sánchez-López, B Chico, M C García-Alonso, R M Lozano
Förderung
- MICIU
- Ministerio de Ciencia, Innovación y Universidades (MICIU/FEDER) in Spain
Zitieren
APA
Sánchez-López, L., Chico, B., García-Alonso, M. C., & Lozano, R. M. (2026). Macrophage proteome modulation induced by tribocorrosion of graphene oxide–hyaluronic acid-coated CoCr surfaces. Biomedical Materials, 21(4), 045033. https://doi.org/10.1088/1748-605x/ae92e2
Vancouver
Sánchez-López L, Chico B, García-Alonso MC, Lozano RM. Macrophage proteome modulation induced by tribocorrosion of graphene oxide–hyaluronic acid-coated CoCr surfaces. Biomedical Materials. 2026;21(4):045033. doi:10.1088/1748-605x/ae92e2
BibTeX
@article{SnchezLpez2026,
author = {Sánchez-López, L and Chico, B and García-Alonso, M C and Lozano, R M},
title = {Macrophage proteome modulation induced by tribocorrosion of graphene oxide–hyaluronic acid-coated CoCr surfaces},
journal = {Biomedical Materials},
year = {2026},
volume = {21},
number = {4},
pages = {045033},
doi = {10.1088/1748-605x/ae92e2}
}
EUVIMED